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Objective: The purpose of this study was to evaluate the effectiveness and demonstrate the advantages of a new technique
for carotid angioplasty and stenting (CAS) with proximal cerebral protection through a direct transcervical approach, as
compared with a percutaneous transfemoral approach.
Methods: Twenty-one CAS procedures were carried out through a 2-cm incision at the base of the neck, under local
anesthesia. For transcervical occlusion and protective shunting (TOPS), a short 9F sheath was inserted directly into the
common carotid artery and connected to a 6F sheath placed percutaneously in the ipsilateral internal jugular vein. After
clamping the common carotid artery proximal to the 9F sheath, internal carotid artery blood flow reversal was confirmed
or an occluding external carotid balloon was placed. A filter interposed between the arterial and venous sheaths collected
embolic debris from transcarotid manipulations. The arterial puncture was directly repaired with suture. Neurologic
status was assessed with the National Institutes of Health stroke scale by an independent neurology consultant before and
after the procedure.
Results: A 0% technical failure rate and a 0% combined 30-day stroke or mortality rate were achieved in all CAS attempted
with TOPS. Angiographic confirmation demonstrated resolution of asymptomatic (>80%; n  8) stenosis or symptom-
atic (>60%; n 12) stenosis. There were no access site complications or hematomas despite pretreatment with clopidogrel
bisulfate and heparin.
Conclusion: TOPS solves problems of access, embolization into the cerebral and peripheral circulation, and specialized
cerebral protection devices, and enables secure closure of the access vessel in patients given anticoagulation therapy. TOPS
may provide a safer, more effective, economical means for performing CAS. (J Vasc Surg 2004;39:994-1002.)Carotid angioplasty and stenting (CAS) is a less invasive
means for treating carotid artery stenosis. Since its intro-
duction two decades ago, use of CAS has steadily increased;
8% of 107,000 carotid procedures performed in Europe in
2001 utilized CAS. The prospect of an outpatient proce-
dure, without the discomfort of a sizable neck incision,
appears to be driving patient decision-making away from
carotid endarterectomy (CEA), the standard procedure for
treating carotid bifurcation disease for the past 50 years.1
However, there are disadvantages to CAS as it is cur-
rently practiced. The standard approach is the femoral
approach. Use of this remote site introduces unnecessary
access difficulties. Tortuous, angulated, and diseased ca-
rotid and aortoiliac vessels, and bovine aortic arch anatomy
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doi:10.1016/j.jvs.2004.01.045994can make reaching the lesion a difficult, if not an impossi-
ble, challenge. The presence of aneurysmal and atheroma-
tous disease of the aorta and its branches contributes to
embolic stroke and peripheral embolization. The Asymp-
tomatic Carotid Atherosclerosis Study documented a
greater than 1% stroke rate for carotid angiography alone.2
The development of cerebral protection devices is unlikely
to decrease this risk, which is incurred before crossing the
lesion, and also puts the contralateral cerebral hemisphere
at risk. The use of femoral access sheaths, especially large
sheaths (7F) increases the risk for life-threatening bleed-
ing and hematoma. Local complications from cardiovascu-
lar interventions range from 18% for compression to 6%
associated with the closure device.3
Although a case report of a more proximal route for
protected (distal balloon) CAS through a transbrachial
approach has been reported,4 the limitations of CAS can be
most completely overcome with cervical carotid artery ac-
cess through a small cutdown incision. This facilitates prox-
imal cerebral protection through flow reversal, and affords
secure closure of the artery. CAS with transcervical occlu-
sion and protective shunting (TOPS) was first performed
on August 23, 2001, after failure of a femoral approach
secondary to severe angulation of the proximal carotid
artery to the aortic arch (Figs 1 and 2).
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Patients. Between August 2001 and August 2003, 20
patients were enrolled in an investigator-sponsored trial of
CAS for bifurcation lesions with the carotid monorail Wall-
stent (Boston Scientific Corp, Natick, Mass) at the
O’Connor Vascular Center. The institutional review board
approved the protocol. Written informed consent was ob-
tained from each patient. All patients were first evaluated
with carotid duplex ultrasound scanning. Inclusion criteria
for the protocol was greater than 50% stenosis in symptom-
atic disease (n  13) and greater than 80% for asymptom-
atic disease (n  8) on the basis of duplex ultrasound
criteria. The sole exclusion criterion was circumferential
heavy calcification of the internal carotid artery. One pa-
Fig 1. The patient, a 72-year-old man with a rigid C-spin
coronary artery disease, diabetes mellitus, chronic renal
failure, had transient ischemic attacks. He had been hosp
previously. A, Aortic arch angiogram reveals 360-deg
170-degree angulation of left proximal common carotid
sheath was briefly placed in the proximal common carot
more purchase over the Amplatz wire. Femoral approach
angulations of 90 degrees or greater (1-5) to treat th
angiogram shows pinhole stenosis.tient with extensive acoustic shadowing at ultrasound scan-
ning was excluded after computed tomography of the neck
confirmed complete calcification of the carotid artery. The
clinical profile of the study group (Table) included four
recurrent stenoses after previous CEA (19%), including one
patient with symptomatic disease. The initial five enrolled
patients were at high risk for CEA. In August of 2002 the
study was opened to patients at average risk, who were
given the option of CEA or CAS with TOPS. All patients
given this option chose CAS with TOPS over CEA. Known
challenges to successful CAS in this study population in-
cluded multiple (three or more) 90-degree carotid artery
angulations (n 3), severe angulation of the carotid artery
takeoff with the aortic arch (n 1), pinhole stenosis of the
cervical fusion; chronic obstructive pulmonary disease,
fficiency, hypertension; and history of congestive heart
ed for 35 days with respiratory failure after CEA 4 years
ight calcified carotid coil without stenosis and acute
y, with aortic arch (1). With difficulty, an MPA guiding
ry ostia, but became dislodged during attempts to gain
id angioplasty and stenting would require traversing five
% internal carotid artery stenosis. B, Selective carotide from
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angled Glidewire (n  3), but no contralateral carotid
artery occlusions.
Preoperative management. Baseline neurologic eval-
uation was performed by a protocol neurologist. Blood
pressure was carefully stabilized (systolic blood pressure
Fig 2. Transcervical occlusion and protective shunting w
and stenting. A, After crossing only the three cephalad s
B, After stent placement and dilation balloon angioplast
patient was discharged to home the next day.
Patient clinical profiles (N  21 procedures)
Demographic n %
Men 17 80
Women 4 20
Symptomatic disease 13 62
Asymptomatic disease 8 38
Degree of stenosis 21 83
Age (y) 73
Coronary artery disease 5 28
Hypertension 17 80
Diabetes mellitus 2 10
COPD 1 5
Chronic renal insufficiency* 3 14
Previous CEA 4 19
Hostile neck 2 10
High or low lesion 3 14
Contralateral occlusion 0 0
Severe carotid angulation 3 14
COPD, Chronic obstructive pulmonary disease; CEA, carotid endarterec-
tomy.
*Creatinine concentration 1.9.160 mm Hg) with oral medications before carotid artery
intervention. Patients with renal insufficiency were given
600 mg of N-acetylcysteine (Mucomyst) every 12 hours for
24 hours before the procedure. All patients were given a
loading dose (300 mg) of clopidogrel bisulfate within 24
hours before the procedure if they were not already receiv-
ing this medication.
CAS with TOPS. This was performed in the operat-
ing theater equipped with an OEC/GE Model 9800 mo-
bile C-arm (GE-OEC, Salt Lake City, Utah). After admin-
istration of mild sedation, a mixture of 1% lidocaine and
0.5% marcaine was used to anesthetize the skin 2 cm above
the clavicle. A 2-cm transverse incision was made, centered
over the medial border of the sternocleidomastoid muscle.
The muscle was retracted laterally, and the common carotid
artery was exposed circumferentially over a length of 2 cm.
The artery was encircled with umbilical tape, and care was
taken to keep the dissection plane directly on the common
carotid artery to avert injury to the vagus nerve. Access was
typically obtained in 5 to 10 minutes.
A 6F introducer sheath was inserted percutaneously
and directed caudad to puncture the internal jugular vein
just above its exposed medial border. After 70 to 100
IU/kg of heparin was administered to raise the activated
clotting time to greater than 250 seconds, an 18-gauge
needle was introduced directly into the common carotid
artery. Injection of contrast material under fluoroscopy in
ccessful after failure of conventional carotid angioplasty
angulations (1, 2, 3), note the stenosis is now occlusive.
Completion angiogram shows a satisfactory result. Theas su
evere
y. C,
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tion and the lesion on a “worst view” magnified angiogram.
All arterial sheaths were placed with road-mapping, to
avoid the diseased artery. A .035 J wire was advanced to
the distal carotid bulb. A 6F short Brite-Tip sheath
(Cordis, Miami, Fla) was passed until the dilator
straightened the J wire; then the sheath was advanced
over the dilator to the distal common carotid artery.
Standard intracranial carotid angiography was performed
(anteroposterior Towne and lateral views) to document
any preexisting intracranial arterial disease and to evalu-
ate collateral circulation.
A 9F Brite-Tip sheath (Cordis) was placed directly in
the common carotid artery, parallel and just above the 6F
introducer sheath with its tip in the distal common carotid
artery. A 5.0 polypropylene (Prolene) Z stitch was placed
around the entrance of the sheath to enable rapid hemosta-
sis of the puncture site in the event of catheter dislodge-
ment. In the last 10 patients a more flexible 9F flexor sheath
(Arrow) was used to facilitate advancement of the sheath
and placement of the Z stitch. An .018 Gold Tip angled
Glidewire (Medi-Tech/Boston Scientific, Natick, Mass)
was directed into the external carotid artery through the 6F
arterial sheath, and a 5-mm angioplasty balloon (Boston
Scientific Corp) or through-the-lumen Fogarty balloon
catheter (Edwards Lifescience, Irvine, Calif) was used to
occlude the proximal external carotid artery. Occlusion of
the external carotid artery and reversal of flow were verified
at angiography after clamping the common carotid artery.
Fig 3. A through-the-lumen Fogarty catheter (e) is u
Antegrade flow through the common carotid artery is ar
Protective shunting of the internal carotid artery blood fl
common carotid artery sheath (a) to a 6F venous sheath
suture around the arterial puncture site and a standard v
common carotid artery are placed for rapid control of
catheter as a result of two 90% angulations of the cervicaThe initial four TOPS procedures were performed with
ultrasound verification of reversed internal carotid artery
flow without external carotid artery balloon occlusion. The
subsequent 17 procedures were performed with routine
balloon occlusion of the external carotid artery to avert
intracranial embolization via external carotid artery collat-
eral vessels.5,6
The sidearm of the 9F sheath was connected to a
60-m filter (Swinnex, Ireland) with holder apparatus
(Millipore), attached to the sidearm of the internal jugular
vein catheter (Fig 3). The clamp was applied to the com-
mon carotid artery, and retrograde flow of contrast material
from the internal carotid artery into the internal jugular
vein was confirmed at fluoroscopy or duplex ultrasound
scanning. The carotid lesion was crossed with a .014 Spar-
tacore guide wire (Guidant, Santa Clara, Calif) under flow-
reversal cerebral protection. Tight lesions were traversed
with an .018 angled Gold-Tip Glidewire and exchanged
over a 4F Guidecatheter (Boston Scientific Corp) for the
.014 Spartacore guide wire. The tight lesion was then
predilated with a 4-mm  4-cm Symmetry (Boston Scien-
tific Corp) angioplasty balloon. If rapid retrograde flow of
contrast material was not seen with initiation of the shunt,
forceful aspiration of blood with a 20-mL syringe through
the 9F sheath was performed after each angioplasty proce-
dure. The blood was returned to the patient through a
three-way stopcock attached to the filter. An 8-mm or 10
24-mm monorail Wallstent (Boston Scientific) was de-
ployed across the lesion into the common carotid artery
or temporary occlusion of the external carotid artery.
with a clamp (c) placed on the common carotid artery.
nto the jugular vein is accomplished by connecting a 9F
via an interposed 60-m filter (f). A 5.0 polypropylene
ar tourniquet and umbilical tape (t) looped around the
stasis. (Note the horizontal orientation of the arterial
tid artery.)sed f
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stent was serially post-dilated with a 5-mm or 6-mm 
2-cm angioplasty balloon (Gazelle; Boston Scientific Corp)
at 8 atm. Completion cervical and intracranial carotid artery
angiography was performed after releasing the external
carotid occlusion balloon and the common carotid clamp
(Fig 4). Once satisfactory treatment of the lesion was
observed, the two arterial sheaths were removed, with
simultaneous repair of the arterial punctures, through the
previously placed exit site sutures. The skin was closed with
4.0 vicryl suture. The venous sheath was left postopera-
tively to facilitate infusion of vasopressor or antihyperten-
sive medications, if needed, and later was removed before
the patient was discharged.
Independent consultation with the protocol neurolo-
gist who had evaluated the patient before the procedure
was obtained before discharge (usually the same day) or
within 24 hours post-procedure. Neurologic status was
assessed with the National Institutes of Health stroke scale.
Each patient was given clopidogrel bisulfate (75 mg/d)
and aspirin for 30 days.
Follow-up. Patients were evaluated with carotid ultra-
sound and clinical examination at 30 days, 6 months, 1
year, and 2 years. No patient was lost to follow-up.
Fig 4. The patient, a 72-year-old obese man with two ep
angioplasty and stenting with transcervical occlusion and
third 90-degree angulation in the internal carotid artery (
balloon occlusion of the external carotid artery (e) with
resolution of the internal carotid artery kink and the shu
shows a satisfactory result.RESULTS
This consecutive series of CAS procedures performed at
the O’Connor Vascular Center over 24 months included
21 CAS procedures in 20 patients.
All 21 CAS procedures were successfully carried out
with TOPS, including in the first patient, in whom trans-
femoral CAS had been attempted unsuccessfully (Figs 1
and 2). Greater than 90% resolution of internal carotid
artery stenosis was achieved in all cases. Lesions treated
included three asymptomatic high-grade recurrent steno-
ses, one symptomatic high-grade recurrent stenosis, five
asymptomatic high-grade stenoses, and 12 symptomatic
moderate or high-grade stenoses. There was no intraoper-
ative or postoperative stroke. One patient with temporary
interruption of proximal shunting as a result of migration of
the venous sheath had amaurosis fugax, which resolved in 2
hours. Significant but momentary bradycardia and hypo-
tension associated with dilation of the internal carotid
artery was observed in two patients. Embolic debris was
recovered in all patients with the external carotid occlusion
technique (n  17); two patients had emboli larger than 2
mm (Fig 5). All patients tolerated continuous proximal
shunting of internal carotid artery blood flow during the
period of guide wire placement, angioplasty, and stent
s of left arm numbness and weakness, underwent carotid
ective shunting. A, Cervical carotid angiogram shows a
ee Fig 3) and an extensive and high lesion (C2). B, After
ective shunting and placement of a Wallstent (C), note
lood in the jugular vein (j). D, Completion angiogramisode
prot
a) (s
prot
nted b
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had intraoperative loss of 1 unit of blood after dislodge-
ment of the arterial catheter before institution of routine
purse-string suture placement. Devices are planned to pre-
vent this inadvertent loss of access.
Postoperatively, no patient had significant hypotension
(systolic blood pressure 90 mm Hg) or hypertension
(systolic blood pressure 160 mm Hg). No intravenous
infusion of antihypertensive medication was necessary.
There were no myocardial infarctions. One patient had
mild hoarseness, which resolved over the course of a
month, presumed to be a result of prolonged traction on
the vagus nerve with a fixed retractor. Since then, fixed
retraction was used sparingly, if at all. Fourteen patients
(66%) were discharged on the day of the procedure.
Follow-up. There were no neck hematomas or wound
complications at the mini-cutdown incision (Fig 6). All
patients underwent follow-up carotid ultrasonography at
30 days, which showed patency of the treated internal
carotid artery without evidence of recurrent stenosis. Du-
Fig 5. Embolic debris collected on the 60-m filter used in a
patient with symptomatic preocclusive carotid stenosis.plex ultrasound scans for all nine patients with 6-month
follow-up and all five patients with 1-year follow-up dem-
onstrated a patent internal carotid artery without recurrent
stenosis. Two patients from the initial high-risk cohort died
during the study period, of myocardial infarction at 5 and 9
months, respectively. Both underwent CAS with TOPS
after initially presentation with neurologic symptoms of
transient ischemic attack (TIA). Family members witness-
ing these events reported no evidence of stroke or TIA
during the follow-up period; however, no autopsies were
performed.
DISCUSSION
Although consensus is building that CAS is preferred in
patients at high risk for treatment of carotid stenosis, many
still consider CEA the standard for treatment of significant
carotid bifurcation disease.7,8 Much discussion has cen-
tered on the expected stroke rate with CAS versus CEA.
Early studies of CAS without cerebral protection reported
higher stroke rates than the best CEA studies.9-11 A meta-
analysis of 26 trials with 2537 unprotected CAS procedures
cited a 6% 30-day stroke mortality rate.12 Some more
recent, albeit smaller, studies with cerebral protection have
approached equipoise,15,16 although the accounting of
strokes in the contralateral hemisphere is not specifically
addressed. A meta-analysis of 11 trials of CAS with cerebral
protection involving 896 procedures showed a 2% 30-day
stroke mortality rate.12 Because CAS from a femoral ap-
proach carries an inherent 1% stroke disadvantage resulting
from angiography, CAS with TOPS potentially brings
stroke risk into parity with CEA by limiting events to
endoluminal or surgical manipulation of the lesion and
cerebral hyperperfusion syndrome.
Proximal shunting with flow reversal with TOPS may
provide better cerebral protection than techniques that
cause emboli by traversing the atheromatous aorta and
aortic arch with large sheath placement or with distal bal-
loon or filter deployment through a femoral carotid access
Fig 6. Patient 1 week after transcervical occlusion and protective
shunting, with mini-cutdown incision.
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Mubarak et al17 documented embolization during carotid
artery sheath placement for distal balloon-protected CAS.
Also demonstrated was microembolization during predila-
tion angioplasty of the lesion, guide wire manipulations,
and distal device retrieval. Additional steps performed with-
out cerebral protection, such as the use of a “buddy wire”
to straighten the internal carotid artery to enable passage of
the distal protection device, have also been associated with
stroke.18
The technical failure of CAS has been reported in the
range of 2% to 10%,8-15,18 with the exception of one study
that reported a 1% failure rate.16 The best technical success
has been achieved with theoretically higher risk techniques,
either without cerebral protection or with low-profile distal
balloons passed unprotected through the lesion. One of the
largest published institutional experiences, by Roubin et
al,10 reported 10 access failures (2%) in a series of 604
unprotected CAS procedures that excluded patients with
vascular disease that precluded femoral access and long
preocclusive carotid lesions. The number of excluded pa-
tients was not specified. These and other authors have
identified failure of placement of the guiding sheath as the
predominant reason for technical failure in selected pa-
tients. If we assume a 2% exclusion rate because of unfavor-
able anatomy, 2% inability to obtain access, and 2% failure
to achieve cerebral protection, a minimum of 6% failure of
transfemoral approach CAS with cerebral protection would
not be an unreasonable conservative estimate in experi-
enced centers. Because of its direct cervical access route, the
primary causes for transfemoral CAS technical failure are
virtually eliminated, and catheter-positioning times are de-
creased with TOPS. Trauma to vessels below the lesion is
minimized and greater mechanical advantage is achieved
from the short access route, which facilitates navigating the
lesion.
Another potential application of TOPS is in treatment
of fibromuscular dysplasia of the carotid artery. Angioplasty
is the accepted and preferred practice. Traditionally, angio-
plasty with serial dilation of the carotid artery has been
performed. More recently, Ballard et al19 described the
procedure with conventional longitudinal exposure of the
common carotid artery and internal carotid artery, with
open flushing of the artery after balloon angioplasty to
prevent embolization. Treatment of fibromuscular dyspla-
sia with TOPS may improve the procedure by decreasing
blood loss through use of the protective venous shunt and
by decreasing the size of the incision. TOPS may also be
used to facilitate and improve the efficiency of emergent
selective intraarterial thrombolysis in acute stroke within
the limited therapeutic window of 6 hours.20
Proponents of CEA believe it is a safer procedure than
CAS. However, general anesthesia used with CEA is asso-
ciated with longer periods of hemodynamic instability than
is sedation used in CAS.21,22 Those who use regional
anesthesia still observe the patient overnight for bleeding.
The often quoted end points of stroke and death do not
fully describe the morbidity of CEA, which has been citedat 12% to 21%.23-26 To illustrate this point, our first patient
to undergo TOPS had previously been hospitalized for 35
days after CEA.
CAS with TOPS averts the long arteriotomy and ve-
nous ligatures of CEA, which are at risk for bleeding. All
cranial nerve injuries are also averted, with the possible
exception of transient vagus nerve paresis. As in conven-
tional CAS, patients benefit from the improved hemody-
namic profile accomplished, with less pain, anesthesia, and
bleeding, which usually enable outpatient procedures.
Moreover, there is an increasing trend for patients with
symptomatic disease needing urgent carotid artery inter-
vention to be given potent thrombolytic, anticoagulation,
and antiplatelet medications. More patients are receiving
thrombolytic therapy for acute stroke. With the aging
population, increasing numbers of patients are taking war-
farin sodium (Coumadin) because of atrial arrhythmias,
myocardial infarction, and congestive heart failure. The
effectiveness of clopidogrel bisulfate and aspirin in decreas-
ing stroke incidence and myocardial infarction27,28 has led
to increased and long-term usage. Payne et al29 demon-
strated a synergistic increase in bleeding time, supporting
the belief of many surgeons that this combination of med-
ications substantially increases the risk for bleeding after
surgery. In many areas, clopidogrel plus aspirin has become
the initial medical therapy for TIA, making CEA more
risky. Direct cervical access enables secure suture closure of
the artery without the need for reversing anticoagulation or
blood product transfusions. Furthermore, TOPS enables
immediate ambulation and averts the increased risk for
infection in the more contaminated groin site used in
conventional CAS.
A small, straightforward cutdown incision is the only
prerequisite for obtaining the advantages of TOPS, as well
as potential new applications for fibromuscular dyplasia and
treatment of acute stroke. There is currently no more
effective closure than a surgical closure. Thus TOPS pro-
vides the opportunity for those with surgical expertise to
perform a safer and more consistently successful CAS while
minimizing the need for advanced endovascular skills and
expensive equipment.
In conclusion, carotid intervention with TOPS has
many conceptual advantages over percutaneous femoral
approaches or CEA, because it addresses the failure modes,
complications, and costs of each of these older treatments
for carotid disease.
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Available online Mar 25, 2004.DISCUSSIONDr Peter Schneider (Honolulu, Hawaii). Well, it looks like a
freeway map. It’s an iatrogenic cerebral steal. It has the disadvan-
tage of a neck incision and questionable durability, so I think the
question is, why not just do an endarterectomy? Thank you.
Just kidding. So this is the deal. All right, the reason to not just
do an endarterectomy is because nobody wants an operation.
Nobody wants our operation anymore, and the sooner we under-
stand that and realize ways to think about who really needs one and
who doesn’t, the happier we are going to be. I think in this case,
the transcervical approach may have some merit. There are
patients that you cannot do transfemorally: a patient with an
occluded external carotid, a patient with a hostile arch. David
deserves quite a bit of credit for really pushing this thing
through. I don’t buy that it is a safer thing, but it is a feasibility
study. It includes cerebral protection. It includes a stent. It issurgeons doing it. It is surgeons innovating. That’s what I like
about it. Innovation is not always pretty the first time you see it,
but this is innovation, and I think he deserves quite a bit of
credit for that. What I don’t like about it is that it is a tacit
admission that we can’t get from the groin to the carotid using
a catheter. You are sort of saying, “Well, since I can’t get from
point A to point B, I am just going to cut down on point B.” I
think that, again, there is a role for this. I don’t think it is going
to replace transfemoral stenting, but I think it has merits, and
we should take a close look.
I have three brief questions. First, what percent of patients do
you think will be candidates for this procedure? Keep in mind, you
have reversed carotid flow, and there are patients, anybody with
common carotid disease, you really can’t treat, because you are
cutting right down on it.
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where your intervention site is, how will you deal with the numer-
ous challenges posed? For instance, there is very short working
room. You are going to have increased radiation exposure. Your
hands are going to be under the image intensifier, or at least very
close. There is potential for unintended guide wire passage into the
carotid bifurcation, because, keep in mind, you are putting in an
access sheath and the distance to the carotid bifurcation is literally
just a couple of centimeters. My own experience is that you really
can’t control wires that well; you are going to have the unintended
1-cm or 2-cm slip distally.
Third, how do you stent across the bifurcation when you have
an occlusion catheter in the external carotid artery at the time?
Dr David W. Chang. In answer to your question about the
percentage of candidates, I think as an initial trial here we did
exclude common carotid lesions. Frankly, it is not necessarily an
absolute contraindication, but for the purpose of this study we did
not include them. I would estimate 110% of transfemoral cases are
candidates. Also, why send your man in New York to do the job in
Hawaii when you can send your man in San Francisco who can do
it just as well, if not better?
To combine my answer to your second question regarding
how you work with a short operating distance, we get an angio-
gram through an angiocath at the time that we make the cutdown,
so we have a good idea of the working distance we can use, and we
put the sheath in at an adequate location. We use road-mapping
techniques so everything is layed out, so you watch the wire go in,
you know exactly where the bifurcation is, and you don’t pass into
the bifurcation. Alternatively you can pass the wire into the exter-
nal and then pass your sheath up into the external carotid, then
withdraw it to the distal bulb.
So far we have not really encountered any problems with any
internal carotid access. The common carotid access is a little bit
more tricky if you have a mid–common carotid lesion. For those
lesions and also for the purposes of streamlining the technique, we
are working on an occlusion balloon system whereby you can
actually put the balloon up so that you don’t have to pass the
sheath up that high. The balloon can be right down the base of the
neck, increasing your working distance.
As far as stenting across the bifurcation, we really have had no
problems with removing the external carotid artery balloon. You
will note that the Wallstent does not have any open wire struts. It
just crosses over the orifice of the external carotid, and it is very easy
with self-expandable stents to pull that occlusion balloon at the
end of the procedure.
Dr Lloyd M. Taylor, Jr (Portland, Ore). Dr Chang, I didn’t
notice in your presentation, but can you tell us what type of
anesthesia you used for these procedures, and what the average
occlusion time was during the procedure?
Dr Chang. We used primary local anesthesia, with a little
sedation at the beginning, just to keep the patient calm, but we like
them to be involved and active to assess their neurologic status
throughout the procedure.
The occlusion times, actually in all our cases, have been
continuous, because patients have tolerated it. However, if you
have a patient with a contralateral occlusion and for some reason
they do not tolerate it, the shunt can be turned on and offperiodically between interventions. We have had patients with
bilateral carotid stenoses, high grade, that have not had problems
with occlusion and reverse flow. I believe one reason is that the
connection between the two sheaths is through a hole that is
actually fairly small, so you have reverse flow, but you don’t have
torrential reverse flow.
Dr Kenneth McIntyre (Las Vegas, Nev). What is your post
stenting protocol for prolonging stent patency?
Dr Chang. Patients get 300 mg of Plavix before the proce-
dure, or they are oftentimes increasingly presenting on Plavix.
They stay on Plavix and aspirin for a month.
Dr Sam Ahn (Los Angeles, Calif). I just have two quick
questions. You have a wonderful opportunity here to show us some
really good physiology. Did you notice in your study, or in your
experience, what percent of patients had flow going from ICA to
ECA versus ECA to ICA? And I guess another question related to
that is what percent of the patients really need that external
balloon?
The second question I have is this: during the balloon occlu-
sion—I think you said this was under local anesthesia—did any
patients have transient TIAs during the occlusion?
Dr Chang. Actually, as far as the flow direction, when I was in
New York we did animal studies with the proximal occlusion
technique, and also I actually measured stump pressures in the OR,
and roughly it is half and half. If you occlude the common carotid,
half go up one way and half go up the other way, and that’s
basically what the Cleveland Clinic group also found when they
studied stump pressures. In cases where the internal carotid pres-
sure is higher, the external carotid balloon helps prevent emboli-
zation of potential collaterals to the ICA or posterior circulation.
As far as any TIAs, we did not have any TIAs with clamping. It
has been at this point uniformly well tolerated, although, as I
mentioned, we did not have any contralateral occlusions yet.
Dr Joseph Rapp (San Francisco, Calif). So what I think
carotid angioplasty has shown us, which we would have not
believed before, is that emboli are incredibly well tolerated by the
brain, much better than we would have ever believed. But emboli
are bad, and I think that there are a lot of accumulating data that
long-term dementia is related to chronic microemboli. What is
known of carotid angioplasty is that there are continuing emboli
after the procedure, more than with endarterectomy. So I am not
throwing the baby out with the bath water; I am just adding a note
of caution. And my question, unrelated to my statement, is, with
the proximal shunt you, and Tak Ohki, and others in New York
have found that there are a certain number of patients who cannot
tolerate this backflow of the internal carotid, and what percentage
of patients is that?
Dr Chang. Again, this is a modest study; currently none, but
there are backups. Either you can do short clampings or you can
have a Percusurge balloon or some distal filter device available. As
far as creating emboli with the protection device, all of these
devices, including distal protection balloons, can create emboli as
you deploy them. I happen to think it is much less with proximal
protection; however, in addition to reverse flow, I aspirate fairly
rigorously at the end of each maneuver, so that all of the debris is
really sucked up that might possibly go up the other way if the
reversed flow is slow.
